IOVA

Iovance Biotherapeutics, Inc.

About IOVA

Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as cancer immunotherapy products designed to harness the power of a patient’s own immune system to eradicate cancer cells. It has developed a new, shorter manufacturing process for tumor infiltrating lymphocyte (TIL) known as Generation 2 (Gen 2), which yields a cryopreserved TIL product. Its lead product candidates include lifileucel for metastatic melanoma and metastatic cervical cancer, as well as LN-145 for metastatic non-small cell lung cancer (NSCLC). In addition, the Company is investigating the combinations of TIL therapy with immune checkpoint inhibitors (ICIs) in metastatic melanoma, cervical cancer (NSCLC), and head and neck squamous cell carcinoma (HNSCC). It is investigating peripheral blood lymphocyte (PBL) therapy for patients with refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

Buy US stocks in Australia starting with IOVA. Open an account and start investing today!

Market Capitalisation

$1.41B

Price-earnings ratio

Dividend yield

0.00%

Volume

High today

$6.27

Low today

$5.92

Open price

$0.00

52-week high

$18.73

52-week low

$5.42

IOVA FAQs

How much is one share of Iovance Biotherapeutics, Inc.?

One share of Iovance Biotherapeutics, Inc. is valued at $5.99.

What is the ticker symbol for Iovance Biotherapeutics, Inc.?

The ticker symbol for Iovance Biotherapeutics, Inc. is IOVA.

How do I buy IOVA shares in Australia?

To buy IOVA stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in IOVA

What is the 52-week high for Iovance Biotherapeutics, Inc. stock?

The Iovance Biotherapeutics, Inc. 52-week high stock price is $18.73.

What is the 52-week low for Iovance Biotherapeutics, Inc. stock?

The Iovance Biotherapeutics, Inc. 52-week low stock price is $5.42.

What is the market capitalisation of Iovance Biotherapeutics, Inc. IOVA?

As of 23/03/2023 Iovance Biotherapeutics, Inc. has a market cap of $1.4B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.